Table 5 |
|
|
Summary of drug therapies |
|
|
Medication |
% of patients who received the therapy |
|
|
|
|
Antimalarial medications, either daily or 3 times weekly |
83.0% |
|
|
|
|
Oral prednisone, either daily or alternate day |
97.8% |
|
|
|
|
Intravenous methylprednisolone pulses (30 mg/kg) at any time during disease course |
67.7% |
|
|
|
|
Cyclophosphamide pulses (500-1000 mg/m2) |
42% |
|
|
|
|
Azathioprine |
45% |
|
|
|
|
Mycofenolate mofetil |
8% |
|
|
|
|
Cyclosporine |
3% |
|
|
|
|
Salah et al. Pediatric Rheumatology 2011 9:36 doi:10.1186/1546-0096-9-36 |
|
